Publisher agreements

A consortial publish-and-read agreement has been made with the American Chemical Society for 2024 - 2026. This gives Charité researchers several advantages. They have access to the publisher's journals and can publish Open Access (OA) in selected journals.

You can publish Open Access in the contract years 2024 - 2026 if the following criteria are met:

• The "Corresponding Author" is a member of the Charité,
• the "Acceptance Date" of your publication is within the term of the contract,
• the journal is hybrid or gold.

Article types that are not covered by the agreement are "Additions", "Corrections" and "Editorials".

For easier assignment to the agreement, we recommend using your Charité email address when submitting.

For the year 2025, a consortial publish-and-read agreement has been reached with the publisher BMJ. This gives Charité scientists several advantages. You have read-only access to the publisher's journals and can publish open access in selected hybrid journals.

You are eligible for publishing if:

• the corresponding author is a member of the Charité,
• the acceptance date of your publication is in 2025,
• your article corresponds to the article type "Research" and
• the journal is one of the 25 journals participating [PDF] in the agreement.

If you have any questions, please feel free to contact us:

Open Access

Members of the Charité - Universitätsmedizin Berlin have reading access to Cambridge University journals in the period 2025 - 2027 and can publish open access in selected journals. This option is made possible by the Charité Medical Library's participation in a consortial publish-and-read agreement.

When you submit your manuscript using your Charité email address, you should automatically be recognized as eligible to publish open access under this agreement.

Under the 2025 - 2027 agreement you can publish open access if the following criteria also apply:

• You are corresponding author
• the acceptance date of your article falls within the agreement period
• your article is a Research Article, Review Article, Rapid Communication, Brief Communication or Case Report
• The journal is hybrid or gold

Please note that color charges are not covered by the agreement and cannot be refunded.

More information about the agreement can be found on the publisher's website.

Charité - Universitätsmedizin Berlin participates in the DEAL agreement with the publisher Elsevier (2024 - 2028).

The complete and continuously updated list of journals [xlsx] that are part of the agreement is provided by Max Planck Digital Library Services gGmbH (MDPLS), which is the service provider for the nationwide DEAL agreements.

Open Access (OA) in Gold OA journals that publish 100% of the articles freely accessible

Elsevier Gold OA journals are labelled ‘Core Gold’ in the journal title list linked above, Gold journals from Cell Press and The Lancet are labelled ‘CP/TL Gold’ (see data sheet included, column C: Bucket). For these journals, the publisher grants journal-specific discounts on the Article Processing Charges (APCs) of 15 or 20 %. The discounted APCs are shown as net prices in the list (see data sheet included, column N: DEAL Cost Contribution).

Financial support from the Publication Fund is possible for articles in these journals, provided that the currently applicable funding criteria are met.

OA in hybrid journals that only make certain articles freely accessible

Elsevier hybrid journals are labelled as ‘Core Hybrid’ in the journal title list linked above; hybrid journals from Cell Press and The Lancet are labelled as ‘CP/TL Hybrid’ (see data sheet included, column C: Bucket).

The costs for OA articles by Charité members published in hybrid journals are fully covered by the PAR fees (Publish-And-Read fees) paid by Charité. There are no costs for you as authors.

Further information on the publication process

For all OA publications, we generally recommend using a CC-BY 4.0 licence, which is compliant with the Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities, of which Charité is a signatory. You can find more information on CC licences on the Medical Library website.

The following criteria must also be met for payment via the DEAL agreement:

• The journal is listed in the above-linked journal title list.
• The ‘Submitting Corresponding Author’ is a member of Charité and correctly states the Charité in the affiliation [PDF].
• The acceptance date is within the term of the DEAL agreement (until the end of 2028).
• The following article types are covered by the DEAL agreement: Full Length Articles, Review Articles, Case Reports, Data in Brief, Microarticle, Original Software Publication, Protocol, Replication Study, Short Communication, Short Survey or Video Article

During submission, please select Charité as the "Corresponding Author's Organisation" in the "Rights and Access" form. If you work at several academic institutions, only select Charité if the main part of your research was conducted here. The Open Access team will then be informed of your article by the publisher and will approve or decline it by the above-mentioned formal criteria for the DEAL agreement.

Please note: In the event of confirmation of an article in a Gold OA journal, we will contact you in a timely manner by e-mail and inform you of the outstanding APC for which the Medical Library must first make advance payments. You will then be asked to provide us with a Charité cost centre (“Kostenstelle”/”Innenauftragsnummer”) so that we can transfer the costs internally.

In hybrid journals, you can also choose to have the article published in closed access, i.e. not freely accessible (so-called "opt-out"). In this case, however, you transfer the exclusive usage rights to the publisher and you or others cannot reuse your article and it can only be read by organizations with a paid subscription. In addition, Charité also has to pay publication costs for opt-out articles under the DEAL agreement. Therefore, please refrain from using this option. If you have opted out and wish to cancel this decision, you can do so until 31 January of the year after publication of your article. Please contact Elsevier author support directly and refer to this for tips (DE) [PDF].

Further information on the practical submission process provided by Elsevier can be found on this page. Please note that the specific conditions for funding and cost coverage applicable for Charité members can only be found on our website.

If you have any questions, please do not hesitate to contact us.

Open Access

A consortial publish-and-read agreement has been made with the publisher Hogrefe for 2024 - 2026. This gives Charité researchers several advantages. They have access to the publisher's journals and can publish Open Access (OA) in selected journals.

If you:

• are a corresponding author with a primary affiliation to Charité
• publish open access in one of the 28 participating journals, and
• are publishing an article type classified as an original work or subcategory thereof,

you will automatically be recognised by the publisher as eligible for open access publication. The costs are (as yet) covered by the Medical Library's subscriptions to the publisher Hogrefe.
Further information on the agreement as well as a list of participating journals can be found on the Hogrefe-website. 
If you have any questions about the procedure, please contact the publisher directly.

Due to the participation of the Medical Library of the Charité in a national consortium agreement (duration 2022-25), where the Article Processing Charges have already been paid, the following possibilities for Open Access publication (under the standard license CC BY 4.0) exist for Charité corresponding authors:

• in hybrid journals (title list (A + B only))
• in gold open access journals (title list (D only)).

The agreement applies to all "Primary Research" articles accepted in the above period, including "research papers", "special issue articles", "letters" and "review articles".

The Charité Medical Library has an agreement with MDPI with an end date of 31.12.24. The agreement provides 10% discount on publication fees. As of 01.01.2025, a discount of 15% on the publication fee for accepted manuscripts will be granted on the basis of a newly signed agreement.

The publication process for authors:

You are a "corresponding author" and submit your manuscript directly to the journal as usual. Please indicate your affiliation with Charité - Universitätsmedizin Berlin upon submission (in the drop-down menu). The publisher will then send you an invoice so that you can make payment.

If you are planning to apply for financial support from the Publication Fund, then please use our online application form (DE).

For the years 2025 ‑ 2027, a consortial publish-and-read agreement has been concluded with the Microbiology Society. This gives Charité scholars several advantages. You have read-only access to the publisher's journals and can publish Open Access (OA) in selected journals. You have read-only access to all titles offered by the Society and can publish Open Access (OA) free of charge in the following journals and platforms:

•  Access Microbiology
• International Journal of Systematic and Evolutionary Microbiology
• Journal of General Virology
• Journal of Medical Microbiology
• Microbial Genomics
• Microbiology

To use the publication component offered, please submit with your Charité e-mail address. Articles must be accepted during the contract period so that they can be processed via the agreement.

An agreement has been concluded with the publisher Portland Press for the years 2025 – 2027. Members of Charité - Universitätsmedizin Berlin have reading access to the publisher's journals and can publish open access (OA) in all seven journals. This option is made possible for Charité members through the Medical Library's participation in a cross-regional consortium agreement for an e-journal package, for which OA rights have been negotiated.

You can publish open access free of charge in the following journals:

• Biochemical Journal
• Biochemical Society Transactions
• Clinical Science
• Essays in Biochemistry
• Emerging Topics in Life Sciences
• Neuronal Signaling
• Bioscience Reports

For questions concerning the workflow, please contact the publisher directly.

This hybrid journal does not qualify for financial support through the Publication Fund.

Due to the participation of the Charité Medical Library in a national consortium agreement, a discount is granted for the Immediate OA , so that a fee of USD 5,300 is charged for the publication of research articles. A publication in Delayed Open Access is subject to a fee of 2,750 USD.

If you have any questions about the discount, please contact the publisher directly.

A consortial publish-and-read agreement has been made with the publisher Rockefeller University Press for 2024 – 2026. This gives Charité researchers several advantages. They have access to the publisher's journals and can publish Open Access (OA) in selected journals.

Your reseach article can be published under the agreement if the following criteria are met:

• The "Corresponding Author" is a member of the Charité,
• the "Acceptance Date" of your publication is within the term of the contract,
• your article will be published in: Journal of Cell Biology (JCB), Journal of Experimental Medicine (JEM) or Journal of General Physiology (JGP).

For the years 2024 ‑ 2025, a consortial publish-and-read agreement has been concluded with the publisher Sage. This gives Charité scholars several advantages. You have read-only access to the publisher's journals and can publish Open Access (OA) in selected journals.

OA in hybrid journals

OA costs are covered by the agreement when Charité corresponding authors publish in „SAGE Choice“ journals and the manuscript is assigned to one of the following article types: Original Research Paper, Review Paper, Brief Communication, Short Reports, or Case Report.

OA Gold Journals

Similarly, Charité corresponding authors receive a 20% discount on publication costs when publishing in a Sage Gold Open Access Journal.

The agreement does not include cost coverage for articles in gold journals. You can still apply to the publication fund if your article meets all funding conditions.

Charité - Universitätsmedizin Berlin participates in the DEAL agreement with the publisher Springer Nature (2024 - 2028).

The Max Planck Digital Library Services (MDPLS) provides a complete and continuously updated list of Springer Nature journals [xlsx] that are part of the DEAL agreement.

Open Access (OA) in Gold OA journals that publish 100% of articles freely accessible

Springer Nature Gold OA journals are labelled as ‘Fully Open Access’ in the list of participating Springer Nature journals linked above. In column J (‘Current DEAL Cost Contribution (2025)’), the discounted Article Processing Charges (APC) are indicated as the net price.

Financial support from the Publication Fund is possible for articles in these journals, provided that the currently applicable funding criteria are met.

The following criteria must also be met for payment via the DEAL agreement:

• The journal appears on the above-linked list of Springer Nature journals that are part of the DEAL agreement and is labelled as ‘Fully Open Access’.
• The ‘Corresponding Author’ is a member of the Charité.
• The following article types are supported by the DEAL agreement. This varies depending on the type of journal:
• Gold OA journals: research articles (= original paper, review paper, brief communication).

Once your article has been reported to the library by the publisher and confirmed for the Charité DEAL account, you will receive an email from the Medical Library's Open Access team. In the case of partial or no funding from the Publication Fund, you will be informed of the gross article fee and, in the case of partial funding, of the amount of funding and asked to provide a Charité cost centre (“Kostenstelle“ or “Innenauftragsnummer“) so that your own contribution to the publication costs can be retrieved. The calculation of the gross article fee is based on the list of participating Springer Nature journals linked above.

Hybrid journals

Springer Nature hybrid journals are labelled ‘Hybrid (Open Choice)’ in the ‘included’ table in the list of participating Springer Nature journals linked above. The costs for Open Access articles published in hybrid journals by Charité members (‘Corresponding Authors’) are covered by the PAR fees (publish-and-read fees) paid by Charité. There are no costs for you as authors.

The following types of contributions are supported by the DEAL agreement. This varies depending on the type of journal:

• Hybrid journals: research articles (= original paper, review paper, brief communication) and non-research articles (= editorial notes, book reviews, letters, reports (except: non-research articles in specialist journals)).

Further information

For all OA publications, we generally recommend using a CC-BY 4.0 licence, which is compliant with the Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities, of which Charité is a signatory. You can find more information on CC licences on the Medical Library website.

Select Charité from the list as ‘Corresponding Author’ when confirming your main affiliation. If you work at several scientific institutions, only select Charité if the majority of your research was carried out there. The Open Access team will then be informed about your article by the publisher and can confirm or reject it for the DEAL agreement.

In hybrid journals, you can also choose to have the article published in closed access, i.e. not freely accessible (opt-out). In this case, you transfer the exclusive rights of use to the publisher and the article cannot be reused by you or others and can only be read by institutions with a paid subscription. Under the DEAL agreement, Charité also has to pay publication costs for opt-out articles. Therefore, please refrain from using this option if possible. If you have decided in favour of this option and wish to cancel the decision, you can do so during the entire term of the agreement.

Please note that you will only find the specific conditions for funding and cost coverage on our website.

If you have any questions about the process, please do not hesitate to contact us.

Open Access 

A consortial publish-and-read agreement has been signed with the publisher Taylor & Francis for the years 2024 - 2026. This gives Charité researchers several advantages. They have read access to the publisher's journals and can publish Open Access in the hybrid Taylor & Francis Open Select Journals (>2,000 journals) at no additional cost.

You are authorised if

• the corresponding author is a member of the Charité,
• the "Acceptance Date" of your publication is in the years 2024, 2025 or 2026
• your article corresponds to the article type Article, Research Article, Review, Review Article, Report, Brief Report, Note, Case Report, Essay, Discussion.

If you fulfil the above criteria, you will receive a 15 % discount on the APC in OA-gold-journals. The Medical Library will make an advance payment for this and then contact you. In the case of partial or no funding from the Publication Fund, you will be informed of the gross article fee and, in the case of partial funding, of the amount of funding and asked to provide a Charité cost centre (“Kostenstelle” or “Innenauftragsnummer”) so that your own share of the publication costs can be booked.

Charité - Universitätsmedizin Berlin participates in the Wiley-DEAL (2024 - 2028).

The Max Planck Digital Library Services (MDPLS) provides a complete and continuously updated list of Wiley journals [xlsx] that are part of the DEAL agreement.

Open Access (OA) in Gold OA journals that publish 100% of articles freely accessible

Wiley Gold OA journals are labelled as ‘OA’ (column ‘Revenue Model’) in the list of participating Wiley journals linked above. Column N (‘EUR APC, Discounted (20%)’) shows the discounted Article Processing Charges (APC) as net price.

Financial support from the Publication Fund is possible for articles in these journals, provided that the currently applicable funding criteria are met.

The following criteria must also be met for payment via the DEAL agreement:

• The journal appears on the list of Wiley journals linked above that are part of the DEAL agreement and is labelled as ‘OA’.
• ‘Corresponding Author’ is a member of the Charité.
• The article type is Primary Research or Review.
• Acceptance Date within the agreement period (until the end of 2028).

Once your article has been reported to the library by the publisher and confirmed for the Charité DEAL account, you will receive an email from the Medical Library's Open Access team. In the case of partial or no funding from the Publication Fund, you will be informed of the gross article fee and, in the case of partial funding, of the amount of funding and asked to provide a Charité cost centre (“Kostenstelle” or “Innenauftragsnummer”) so that your own contribution to the publication costs can be retrieved. The calculation of the article gross fee is based on the list of participating Wiley journals linked above.

Hybrid journals

Wiley hybrid journals are labelled ‘HOA’ in column G ‘Revenue Model’ in the list of participating Wiley journals linked above. The costs for Open Access articles published in hybrid journals by Charité members (‘Corresponding Authors’) are covered by the PAR fees (publish-and-read fees) paid by Charité. There are no costs for you as authors.

The article type must also be Primary Research or Review for Open Access articles in hybrid journals.

Further information

For all OA publications, we generally recommend using a CC-BY 4.0 licence, which is compliant with the Berlin Declaration on Open Access to Knowledge in the Sciences and Humanities, of which Charité is a signatory. You can find more information on CC licences on the Medical Library website.

The publication process differs depending on whether you submit your manuscript to a pure OA journal or a hybrid journal.

In the case of an OA journal, you select Charité as your institution when submitting. Charité has the code ‘D052’. Wiley describes the entire process with screenshots in its instructions (PDF).

For a hybrid journal, you can select ‘Hybrid Open Access’ when accepting your article. Confirm your Charité affiliation. Wiley describes the entire process with screenshots in its instructions (PDF).

If you work at several academic institutions, only select Charité if the majority of your research took place there. The Open Access team will then be informed about your article by the publisher and can confirm or reject it for the DEAL agreement.

In hybrid journals, you can also choose to have the article published in closed access, i.e. not freely accessible (opt-out). In this case, you transfer the exclusive rights of use to the publisher and the article cannot be reused by you or others and can only be read by institutions with a paid subscription. Under the DEAL agreement, Charité also incurs publication costs for opt-out articles. Therefore, please refrain from using this option if possible. If you have decided in favour of this option and wish to cancel the decision, you can do so during the entire term of the agreement.

Please note that you will only find the specific conditions for funding and cost coverage on our website.

If you have any questions about the procedure, please do not hesitate to contact us.

Open Access